697 related articles for article (PubMed ID: 29282133)
1. Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?
Deng Z; Sheehan P; Chen S; Yue Z
Mol Neurodegener; 2017 Dec; 12(1):90. PubMed ID: 29282133
[TBL] [Abstract][Full Text] [Related]
2. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Weishaupt JH; Hyman T; Dikic I
Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
[TBL] [Abstract][Full Text] [Related]
3. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
Gascon E; Gao FB
J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814
[TBL] [Abstract][Full Text] [Related]
4. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.
Root J; Merino P; Nuckols A; Johnson M; Kukar T
Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000
[TBL] [Abstract][Full Text] [Related]
5. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
Jovičić A; Paul JW; Gitler AD
J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
[TBL] [Abstract][Full Text] [Related]
6. The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway.
Ciura S; Sellier C; Campanari ML; Charlet-Berguerand N; Kabashi E
Autophagy; 2016 Aug; 12(8):1406-8. PubMed ID: 27245636
[TBL] [Abstract][Full Text] [Related]
7. UBQLN2/P62 cellular recycling pathways in amyotrophic lateral sclerosis and frontotemporal dementia.
Fecto F; Siddique T
Muscle Nerve; 2012 Feb; 45(2):157-62. PubMed ID: 22246868
[TBL] [Abstract][Full Text] [Related]
8. Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the
Dols-Icardo O; García-Redondo A; Rojas-García R; Borrego-Hernández D; Illán-Gala I; Muñoz-Blanco JL; Rábano A; Cervera-Carles L; Juárez-Rufián A; Spataro N; De Luna N; Galán L; Cortes-Vicente E; Fortea J; Blesa R; Grau-Rivera O; Lleó A; Esteban-Pérez J; Gelpi E; Clarimón J
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):162-168. PubMed ID: 28889094
[TBL] [Abstract][Full Text] [Related]
9. Tale of two diseases: amyotrophic lateral sclerosis and frontotemporal dementia.
Verma A
Neurol India; 2014; 62(4):347-51. PubMed ID: 25237937
[TBL] [Abstract][Full Text] [Related]
10. Impaired protein degradation in FTLD and related disorders.
Götzl JK; Lang CM; Haass C; Capell A
Ageing Res Rev; 2016 Dec; 32():122-139. PubMed ID: 27166223
[TBL] [Abstract][Full Text] [Related]
11. TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts.
Le Ber I; De Septenville A; Millecamps S; Camuzat A; Caroppo P; Couratier P; Blanc F; Lacomblez L; Sellal F; Fleury MC; Meininger V; Cazeneuve C; Clot F; Flabeau O; LeGuern E; Brice A;
Neurobiol Aging; 2015 Nov; 36(11):3116.e5-3116.e8. PubMed ID: 26476236
[TBL] [Abstract][Full Text] [Related]
12. ALS and FTD: Where RNA metabolism meets protein quality control.
Mandrioli J; Mediani L; Alberti S; Carra S
Semin Cell Dev Biol; 2020 Mar; 99():183-192. PubMed ID: 31254610
[TBL] [Abstract][Full Text] [Related]
13. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R; Neumann M
Lancet Neurol; 2010 Oct; 9(10):995-1007. PubMed ID: 20864052
[TBL] [Abstract][Full Text] [Related]
14. Delineating the relationship between amyotrophic lateral sclerosis and frontotemporal dementia: Sequence and structure-based predictions.
Kumar V; Islam A; Hassan MI; Ahmad F
Biochim Biophys Acta; 2016 Sep; 1862(9):1742-54. PubMed ID: 27318084
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of the TIA1 gene in Chinese patients with amyotrophic lateral sclerosis and frontotemporal dementia.
Yuan Z; Jiao B; Hou L; Xiao T; Liu X; Wang J; Xu J; Zhou L; Yan X; Tang B; Shen L
Neurobiol Aging; 2018 Apr; 64():160.e9-160.e12. PubMed ID: 29370934
[TBL] [Abstract][Full Text] [Related]
16. Making connections: pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia.
Fecto F; Siddique T
J Mol Neurosci; 2011 Nov; 45(3):663-75. PubMed ID: 21901496
[TBL] [Abstract][Full Text] [Related]
17. Evidence of a link between ubiquilin 2 and optineurin in amyotrophic lateral sclerosis.
Osaka M; Ito D; Yagi T; Nihei Y; Suzuki N
Hum Mol Genet; 2015 Mar; 24(6):1617-29. PubMed ID: 25398946
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models.
Nolan M; Talbot K; Ansorge O
Acta Neuropathol Commun; 2016 Sep; 4(1):99. PubMed ID: 27600654
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal Dysfunction at the Centre of Parkinson's Disease and Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.
Wallings RL; Humble SW; Ward ME; Wade-Martins R
Trends Neurosci; 2019 Dec; 42(12):899-912. PubMed ID: 31704179
[TBL] [Abstract][Full Text] [Related]
20. Association between TBK1 mutations and risk of amyotrophic lateral sclerosis/frontotemporal dementia spectrum: a meta-analysis.
Cui R; Tuo M; Li P; Zhou C
Neurol Sci; 2018 May; 39(5):811-820. PubMed ID: 29349657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
